Neomatrix, UND partner to develop technology for early detection of breast cancer

The University of North Dakota and Neomatrix, LLC, have signed an exclusive agreement to develop technology for the early detection of breast cancer using the company’s HALO Breast Pap Test device.

See the article here:
Neomatrix, UND partner to develop technology for early detection of breast cancer

NeoMatrix, LLC, Makers of HALO® Breast Pap Test for Breast Cancer Risk Assessment Announces New Management

NeoMatrix, LLC, a breast health solutions company, today announced a new executive management team. CEO and President, France Dixon Helfer states, “I am excited about repositioning and expanding the NeoMatrix HALO technology platform, which plays an important role in screening for early detection of breast cancer.

Read the article:
NeoMatrix, LLC, Makers of HALO® Breast Pap Test for Breast Cancer Risk Assessment Announces New Management

Guided Therapeutics LuViva Advanced Cervical Scan Under Review by United Kingdoms NHS Diagnostics Assessment Programme

Guided Therapeutics, Inc. (OTCBB OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection …

See more here:
Guided Therapeutics LuViva Advanced Cervical Scan Under Review by United Kingdoms NHS Diagnostics Assessment Programme

Ovarian Cancer Facts & Statistics

Ovarian cancer is a growth of malignant cells that begins in a womans ovaries.

Taken from:
Ovarian Cancer Facts & Statistics

Guided Therapeutics Enters into Preliminary Research Agreement with Konica Minolta Opto in Anticipation of Asian …

Guided Therapeutics, Inc. (OTCBB OTCQB: GTHP), developer of a rapid and painless biophotonic testing platform for the early detection of cancer, …

More:
Guided Therapeutics Enters into Preliminary Research Agreement with Konica Minolta Opto in Anticipation of Asian …